PCA
MDT icon

Pallas Capital Advisors’s Medtronic MDT Stock Holding History

Pallas Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Sell
16,707
-7,718
-32% -$739K 0.05% 251
2025
Q4 		$2.35M Sell
24,425
-350
-1% -$34K 0.08% 196
2025
Q3 		$2.36M Buy
24,775
+5,219
+27% +$480K 0.09% 184
2025
Q2 		$1.7M Sell
19,556
-1,097
-5% -$93K 0.06% 219
2025
Q1 		$1.86M Buy
20,653
+10,696
+107% +$957K 0.08% 193
2024
Q4 		$795K Sell
9,957
-1,597
-14% -$138K 0.03% 282
2024
Q3 		$1.05M Buy
11,554
+3,747
+48% +$315K 0.05% 220
2024
Q2 		$634K Buy
7,807
+1,043
+15% +$85.5K 0.03% 274
2024
Q1 		$589K Buy
6,764
+696
+11% +$59.4K 0.02% 260
2023
Q4 		$500K Buy
6,068
+212
+4% +$16.2K 0.03% 263
2023
Q3 		$410K Buy
5,856
+1,191
+26% +$99.7K 0.03% 257
2023
Q2 		$405K Sell
4,665
-83,859
-95% -$7.22M 0.02% 207
2023
Q1 		$7.94M Buy
88,524
+24,547
+38% +$2M 0.74% 36
2022
Q4 		$5.18M Sell
63,977
-30,547
-32% -$2.48M 0.52% 55
2022
Q3 		$7.94M Sell
94,524
-233
-0.2% -$20.9K 0.88% 29
2022
Q2 		$8.6M Buy
94,757
+6,335
+7% +$642K 1.18% 16
2022
Q1 		$9.64M Buy
88,422
+6,530
+8% +$690K 1.23% 17
2021
Q4 		$8.65M Buy
81,892
+7,836
+11% +$907K 1.05% 18
2021
Q3 		$8.97M Buy
74,056
+15,810
+27% +$2.05M 0.99% 18
2021
Q2 		$7.48M Buy
58,246
+7,673
+15% +$963K 1.05% 16
2021
Q1 		$6.42M Buy
+50,573
New +$5.93M 1.43% 11

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pallas Capital Advisors's MDT Position: Q1 2026 in Review

Pallas Capital Advisors reduced its Medtronic (MDT) stake by 32% in Q1 2026, selling an estimated $739K and leaving 16,707 shares worth $1.45M. The position accounts for 0.05% of the portfolio, ranked #251.

Pallas Capital Advisors first reported a position in MDT in Q1 2021 and has held it in 21 quarters since. The position peaked at $9.64M in Q1 2022. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Pallas Capital Advisors held 16,707 shares of Medtronic worth $1.45M as of Q1 2026.
  • Pallas Capital Advisors sold 7,718 Medtronic shares in Q1 2026, an estimated $739K.
  • Medtronic made up 0.05% of Pallas Capital Advisors's portfolio in Q1 2026, its #251 holding.
  • Pallas Capital Advisors first reported a position in Medtronic in Q1 2021 and has held it in 21 quarters since.
  • Pallas Capital Advisors's Medtronic position peaked at $9.64M in Q1 2022.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Pallas Capital Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.